Targanta Therapeutics Files to Raise up to $86.3 Million in IPO

WASHINGTON, May 11 (Reuters) - Biopharmaceutical company Targanta Therapeutics Corp. filed with regulators on Friday to raise up to $86.25 million in an initial public offering of common stock.

>>> Discuss This Story

Back to news